title: Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty.
authors.affiliation: Department of Medicine, Asan Medical Center, University of Ulsan, Seoul, South Korea.
authors.forename: Cheol Whan
authors.initials: CW
authors.lastname: Lee
authors.forename: Dae-Hyuk
authors.initials: DH
authors.lastname: Moon
authors.forename: Myeong-K i
authors.initials: MK
authors.lastname: Hong
authors.forename: Jae-Hwan
authors.initials: JH
authors.lastname: Lee
authors.forename: S i-Wan
authors.initials: Si
authors.lastname: Choi
authors.forename: Hyun Suk
authors.initials: HS
authors.lastname: Yang
authors.forename: Jae-Joong
authors.initials: JJ
authors.lastname: Kim
authors.forename: Seong-Wook
authors.initials: SW
authors.lastname: Park
authors.forename: Seung-Jung
authors.initials: SJ
authors.lastname: Park
mesh_terms: D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab